R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis

NCT02842931 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

NETWORK

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma

Interventions

DRUG: R-DA-EPOCH-21
DRUG: R-DA-EPOCH-21 + auto-SCT
DRUG: R-mNHL-BFM-90
DRUG: R-mNHL-BFM-90 + auto-SCT

Sponsor

National Research Center for Hematology, Russia

Collaborators

[object Object]